Test results boost ReGen shares.
Investors Chronicle - magazine and web content, August, 2007
ReGen's shares are up nearly 20 per cent after positive data from trials of its neurological drug, zolpidem Piper Terrett
Shares in ReGen Therapeutics jumped 19 per cent to 0.925p after encouraging results from small trials of neurological product zolpidem.
The product is being developed to 'awaken' patients in a dormant state induced by brain damage suffered in an ...
Most Recent Business Articles
- How do I determine my retainer fee?
- Why fly solo when an executive assistant can accelerate your CLNC® business?
- The CLNC® mentors held the key to my first case and to my CLNC® success
- Atlanta CLNC® 6-day certification seminar photo gallery—plus sign up today for spring 2009 to save $100.00
- Speak to a full-time practicing CLNC® consultant
Most Recent Business Publications
Most Popular Business Articles
- Using object-oriented analysis and design over traditional structured analysis and design
- Big Fish Games Migrates Upstream to Fisher Plaza; High Growth Online Gaming Firm Vaults Fisher Plaza Occupancy Rate Above 90%
- Top of the line: some of the world's most well-respected doctors practice in South Florida. A guide to choosing the best physician specialists - Top Doctors in South Florida
- Sand filter basics: high-rate sand filters can be confusing for those new to the business. Understanding valve modes is the key
- BEHR Paints Introduces a Colorful New Way to Paint and Prime All in One with BEHR Premium Plus Ultra™ Interior
Sponsored by Merrill Lynch